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etiology which can take several decades to
progress in man. The early phases, which are
normally asymptomatic, are characterized by focal
cartilage lesions accompanied by cartilage and
bone hypertrophy. With progression, cartilage
becomes extensively eroded, exposing bone. The
bone shows areas of necrosis and active re-
modeling. A synovitis may become established
leading to leukocyte infiltration, capsular thicken-
ing and altered synovial cell metabolism. The
altered synovial cell metabolism is reflected in
reduced synthesis of hyaluronan, the visco-elastic
component of synovial fluid.
These multiple time-dependent events are di$-
cult to reproduce collectively in animal models
and impossible to simulate in vitro. For these
reasons the evaluation of the e#ects of non-
steroidal antiinflammatory drugs (NSAIDs) on the
progression of OA in models has, for the most
part, focused on specific joint tissues, particularly
cartilage and bone.
Rodent models of OA have generated conflicting
results on the e#ects of NSAIDs on cartilage
metabolism. The models have included (1) OA
induced by surgical destabilization of joints; (2)
OA induced by injection of enzymes or chemicals
into joints; (3) OA induced by selective breeding to
intensify a genetic defect. The di#erent etiologies,
variable rates of progression and doses/routes
of drugs administered could account for these
discrepancies.
Large animal models of traumatic OA o#er many
advantages over rodent models. If pure bred
animals of similar sex and weight are used, the
induced lesions are reproducible, are slower to
progress and correspond more faithfully to the
pathological changes which occur in human
OA joints. Moreover, since the joints are larger,
topographical sampling of cartilage and sub-
chondral bone can be undertaken and synovial340fluid aspirated serially. The method used to induce
OA can be chosen to mimic a common human
injury which is known to lead to OA, e.g., transec-
tion of the anterior cruciate ligament (ACL) or
meniscectomy. Transection of the ACL in the
canine has been widely used as a model of OA and
the e#ects of both NSAIDs and other anti-arthritic
drugs on cartilage metabolism and release of bio-
chemical marker into synovial fluid described
[1–4]. Since meniscal tears and meniscectomy are
common causes of OA in humans, we have favored
this surgical procedure to induce OA in joints of
pure bred dogs [5] or sheep [6–9].
Using the sheep meniscectomy model, we
examined the e#ects of tiaprofenic acid [10], intra-
articular hyaluronan [11], pentosan polysulphate
[12] and diacerhein (DIA) [13] on structural
changes in joint cartilage and subchondral bone as
a function of time. In the study with DIA, animals
were given the drug orally once a day for 3 and
9 months. At death, cartilage was examined for
histologic and biochemical changes including gly-
cosaminoglycan and matrix metalloproteinase
content. The ratio of thickness of the subchondral
plate (calcified cartilage+subchondral bone) to
uncalcified cartilage were determined, in the
inner, middle and outer zones of the lateral
femoral condyles and tibial plateaux. The histo-
logic studies showed that the cartilage damage
was greater in the DIA-treated animals 3 months
post-OA induction. However, this situation was
reversed by 9 months. In contrast to the histologic
studies, topographic analyses of the ratio of
subchondral bone to cartilage thickness showed
no di#erence between treated groups by 3 months
however, after 9 months the middle joint zone (the
primary lesion site) of the DIA-treated group was
not distinguishable from the non-operated control
group (NOC) but lower than in the same region of
the non-drug-treated OA group (Fig. 1).
Osteoarthritis and Cartilage Vol. 7 No. 3 341These data demonstrate that the e#ects of
NSAIDs on disease progression in OA can be
determined in animal models such as the sheep
meniscectomy model, provided careful topographi-
cal and zonal analysis of joint tissues is under-
taken to allow the subtleties of the structural
changes which occur in bone and cartilage to be
identified and quantitated.2.5
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FIG. 1. The ratio of subchondral plate (SCP) thickness to uncalcified cartilage (UCC) thickness (mean&SEM) of inner
(/), middle ( ) and outer (.) zones of the lateral tibial plateaux from normal (NOC) and OA sheep joints with or
without Diacerhein (DIA) treatment, 3 and 9 months post-OA induction.1References
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